INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS

Infertility Drugs and Devices Market, By Type (Infertility Drugs (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, Metformin), Infertility Devices (Equipment, Accessories)), By Gender (Male, Female), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI4122
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Infertility Drugs And Devices MarketSize and Trends

The global infertility drugs and devices market is estimated to be valued at US$ 7.6 billion in 2023 and is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

The global Infertility Drugs and Devices market is expected to witness growth, as manufacturers are launching new and improved products and drugs, and investing more in research & development. Improved healthcare services, medical devices, and phototherapy equipment are expected to drive the market growth

Market- Trends

Initiatives to increase awareness regarding human reproductive technologies

Initiatives to increase awareness regarding human reproductive technologies is expected to propel growth of the market. For instance, in February 2020, Cryos USA, a sperm and egg bank based in the U.S., held a scientific symposium on Assisted Reproductive Technology (ART).